Literature DB >> 27018225

Absolute lymphocyte count as a prognostic marker in newly diagnosed multiple myeloma patients.

C Suriu1, L Akria1, D Azoulay2, E Shaoul2, M Barhoum3, A Braester4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27018225     DOI： 10.1111/ijlh.12482

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN： 1751-5521            Impact factor:   2.877


× No keyword cloud information.
  5 in total

1.  The (Neutrophils + Monocyte)/Lymphocyte Ratio Is an Independent Prognostic Factor for Progression-Free Survival in Newly Diagnosed Multiple Myeloma Patients Treated With BCD Regimen.

Authors:  Yanbin Pang; Hong Shao; Ziheng Yang; Lixia Fan; Wenwen Liu; Jianhong Shi; Yuqing Wang; Ying Han; Lin Yang
Journal:  Front Oncol       Date:  2020-09-02       Impact factor: 6.244

2.  Significance of the absolute lymphocyte/monocyte ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma.

Authors:  T Dosani; F Covut; R Beck; J J Driscoll; M de Lima; E Malek
Journal:  Blood Cancer J       Date:  2017-06-30       Impact factor: 11.037

3.  Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.

Authors:  Xiangxiang Zhou; Xiaogang Sun; Wenbo Zhao; Xiaosheng Fang; Xin Wang
Journal:  Cancer Manag Res       Date:  2019-05-07       Impact factor: 3.989

4.  Association of CD117 and HLA-DR expression with shorter overall survival and/or progression-free survival in patients with multiple myeloma treated with bortezomib and thalidomide combination treatment without transplantation.

Authors:  Huan Wang; Xin Zhou; Jian-Wei Zhu; Jian-Nan Ye; Hong-Feng Guo; Chao Sun
Journal:  Oncol Lett       Date:  2018-08-24       Impact factor: 2.967

5.  Peripheral Absolute Lymphocyte Count: An Economical and Clinical Available Immune-Related Prognostic Marker for Newly Diagnosed Multiple Myeloma.

Authors:  Ying Yang; Zhuogang Liu; Hongtao Wang
Journal:  Med Sci Monit       Date:  2020-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.